Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.96
-0.83 (-5.61%)
At close: Oct 28, 2025, 4:00 PM EDT
14.26
+0.30 (2.15%)
Pre-market: Oct 29, 2025, 4:25 AM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.5 billion as of October 28, 2025. Its market cap has decreased by -17.07% in one year.
Market Cap
1.50B
Enterprise Value
970.65M
1-Year Change
-17.07%
Ranking
Category
Stock Price
$13.96
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.50B, an increase of 97.83%. That is a compound annual growth rate of 7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 1.59B | 33.69% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.16B |
| Johnson & Johnson | 451.73B |
| AbbVie | 397.30B |
| UnitedHealth Group | 326.32B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.75B |